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Mycoplasma bovis causes bovine mycoplasmosis. The major clinical manifestations are
pneumonia and mastitis. Recently an increase in the severity of mastitis cases was
reported in Switzerland. At the molecular level, there is limited understanding of the
mechanisms of pathogenicity of M. bovis. Host–pathogen interactions were primarily
studied using primary bovine blood cells. Therefore, little is known about the impact ofM.
bovis on other cell types present in infected tissues. Clear in vitro phenotypes linked to the
virulence ofM. bovis strains or tissue predilection of specificM. bovis strains have not yet
been described. We adapted bovine in vitro systems to investigate infection of epithelial
cells with M. bovis using a cell line (MDBK: Madin-Darby bovine kidney cells) and two
primary cells (PECT: bovine embryonic turbinate cells and bMec: bovine mammary gland
epithelial cells). Two strains isolated before and after the emergence of severe mastitis
cases were selected. Strain JF4278 isolated from a cow with mastitis and pneumonia in
2008 and strain L22/93 isolated in 1993 were used to assess the virulence of M. bovis
genotypes toward epithelial cells with particular emphasis on mammary gland cells. Our
findings indicate that M. bovis is able to adhere to and invade different epithelial cell
types. Higher titers of JF4278 than L22/93 were observed in co-cultures with cells. The
differences in titers reached between the two strains was more prominent for bMec cells
than for MDBK and PECT cells. Moreover, M. bovis strain L22/93 induced apoptosis
in MDBK cells and cytotoxicity in PECT cells but not in bMec cells. Dose-dependent
variations in proliferation of primary epithelial cells were observed afterM. bovis infection.
Nevertheless, an indisputable phenotype that could be related to the increased virulence
toward mammary gland cells is not obvious.
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INTRODUCTION
Mycoplasma bovis was first isolated in 1961 in the United States from a dairy herd with an
outbreak of mastitis (Hale et al., 1962). M. bovis is one of the major causative agents of
bovine mycoplasmosis. Clinical manifestations are broad, including bronchopneumonia, mastitis,
otitis, arthritis, keratoconjunctivitis, meningitis, and genital disorders (Bürki et al., 2015a). This
bacterium is an emerging pathogen in industrialized countries, leading to high economic losses in
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dairy and beef cattle production. Management of bovine
mycoplasmosis is challenging as chronic infections in
combination with subclinical development of the disease
are often observed (Maunsell et al., 2011; Nicholas, 2011).
Furthermore, current vaccines are ineffective in the field
and antibiotic treatments generally fail, while resistance to
antimicrobials is increasing (Gautier-Bouchardon et al., 2014;
Perez-Casal et al., 2017).
In Switzerland, M. bovis was predominantly associated with
pneumonia and subclinical mastitis (Burnens et al., 1999). In
the mid-2000s, a rise in the severity of mastitis cases due to
M. bovis was observed (Aebi et al., 2012, 2015). A similar
trend was documented in Northern Italy (Radaelli et al., 2011),
Austria (Spergser et al., 2013), and Israel (Lysnyansky et al.,
2016). Molecular epidemiology studies of Austrian and Swiss
strains revealed distinct genotypes suggesting a switch in the
circulating M. bovis genotypes in Switzerland in parallel with an
increased number of severe mastitis cases (Bürki et al., 2016).
However, it remains unclear whether the currently circulating
M. bovis strains show higher predilection or virulence toward
mammary gland cells than older strains (Bürki et al., 2016).
Tissue predilection of specific M. bovis strains has not been
previously reported. Past research focused mainly on blood cells
and partially neglected a potential role of other cell types like
epithelial cells in disease development.
To establish an efficient infection, bacteria have to adhere to
host cells, multiply or persist in the host, and evade the host
immune system. Several mechanisms of pathogenicity of M.
bovis have been described and disease development seems to be
multifactorial (Bürki et al., 2015a). Adhesion is one of the first
steps of mycoplasma infection (Rottem, 2003). Several surface
exposed proteins were characterized as adhesins (Sachse et al.,
1993, 1996, 2000; Thomas et al., 2003b). However, the molecular
mechanisms of cell-dependent adhesion are still not understood
due to a lack of knowledge of the corresponding eukaryotic
receptors. Recently, three adhesins were identified: α-enolase,
NOX and TrmFO. They were shown to bind to plasminogen and
fibronectin, serving as a bridge between the bacterial adhesins
and the host cell receptors (Song et al., 2012; Guo et al., 2017;
Zhao et al., 2017). Binding to plasminogen and fibronectin might
facilitate invasion and dissemination in the host, as described
for other bacteria (Raymond and Djordjevic, 2015). Occasional
intracellular localization of M. bovis in inflammatory host cells
was previously shown in vivo (Adegboye et al., 1995; Rodríguez
et al., 1996; Maeda et al., 2003; Kleinschmidt et al., 2013).
More recently, in vitro uptake of M. bovis by several bovine
blood cell types was demonstrated (van der Merwe et al., 2010;
Suleman et al., 2016; Jimbo et al., 2017; Bürgi et al., 2018).
Moreover, invasion of primary embryonic calf turbinate (PECT)
cells, the Embryonic Bovine Lung (EBL) cell line, and the
Embryonic Bovine Tracheal (EBTr) cell line was shown (Bürki
et al., 2015b; Suleman et al., 2016). To date, the molecular
mechanisms involved in M. bovis invasion of bovine cells and
a potential differential permissivity dependent on the cell type
have not been described. Invasion of M. bovis in different cell
types might contribute to the pathogenicity of the bacterium.M.
bovis may reside in a protective niche evading the host immune
response and antimicrobial treatment. Furthermore, invasion
of host blood cells could also lead to systemic spread of this
bacterium (Bürki et al., 2015a).
In vitro studies indicated that cytotoxicity, apoptosis and host
cell proliferation after infection with M. bovis differ among host
cell types (Bürki et al., 2015a). Infected PBMCs were studied,
considering cytotoxic effects, induction of apoptosis and viability
of host cells, but results were inconsistent (Vanden Bush and
Rosenbusch, 2002; van der Merwe et al., 2010; Gondaira et al.,
2015). However, M. bovis was shown to inhibit proliferation of
PBMCs (Vanden Bush and Rosenbusch, 2002; van der Merwe
et al., 2010; Suleman et al., 2016, 2018). Studies analyzing distinct
blood cell types gave clearer results. M. bovis infection delayed
apoptosis in monocytes (Mulongo et al., 2014) and alveolar
macrophages (Suleman et al., 2016), whereas a reduction in
host cell viability and induction of apoptosis was observed in
infected neutrophils (Jimbo et al., 2017). Additionally, a slight
induction of apoptosis and cytotoxicity after M. bovis infection
was observed in bovine macrophage cell lines (Bürgi et al., 2018).
Compared to blood cell types, little is known about the effects of
M. bovis on epithelial cells. M. bovis infection induced a slight
cytotoxic effect in bovine endothelial cells, whereas a strong
increase in apoptosis was observed in human epithelial cells
(Sokolova et al., 1998; Lu and Rosenbusch, 2004).
Knowledge of M. bovis effects on epithelial cells is
fragmentary. In the present study, host–M. bovis interactions
using bovine epithelial cells from different organs were
investigated. The aim of the study was to identify virulence
phenotypes in bovine epithelial cells resulting from infection
with two strains of M. bovis, with a focus on bovine epithelial
mammary gland cells.
MATERIALS AND METHODS
Bacterial Strains and Axenic Growth
Conditions
M. bovis strains L22/93 and JF4278 were used. Strain L22/93
was isolated in 1993 in Switzerland from the lung of a cow.
This strain was assigned to the sequence type (ST) 17 by
multilocus sequence typing (MLST) (Bürki et al., 2016). Strain
JF4278 was isolated from the milk of a cow with mastitis
and pneumonia in Switzerland in 2008 (Aebi et al., 2012).
This strain was originally submitted to the database as ST
5 on the basis of sequencing PCR amplicons (Bürki et al.,
2016). It was later discovered that the adh-1 allele assignment
was incorrect and that the isolate actually lacks that locus.
The current, updated pubMLST profile (https://pubmlst.org/
bigsdb?db=pubmlst_mbovis_isolates), including the absence of
the adh-1 locus, is consistent with the genome sequence data
(Genbank accession number: NZ_LT578453.1). This finding was
subsequently confirmed by repeating the analysis of the isolate
based on PCR. The missing adh-1 locus means that the isolate
is not typeable by the MLST reference method. Other isolates
similarly lacking the adh-1 locus have also been identified. As a
result, an effort to modify the scheme to restore the ability to type
all isolates is underway. There are a number of other isolates in
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the pubMLST database for which no adh-1 locus is given. Strains
of M. bovis were grown at 37◦C in SP4 medium (Freundt, 1983)
supplemented with 50µg/mL cefoxitin sodium salt (Sigma-
Aldrich, Buchs, Switzerland). Pre-cultures were grown for 20 h
from frozen stocks diluted 1:100 in SP4 broth medium. The
concentration of all pre-cultures was measured by performing
10-fold serial dilutions and plating on SP4 agar plates. SP4 agar
plates were incubated at 37◦C for 4–5 days in a humidified
atmosphere. Colonies were counted under a stereomicroscope.
For standardization purposes, growth of each frozen bacterial
stock and SP4 batches were tested. The generation time of both
strains was assessed in a previous study, JF4278 had a generation
time of 1.52 h ± 0.08, while L22/93 had a generation time of
2.01 h± 0.16 (Bürgi et al., 2018).
Epithelial Cells and Cell Infections
Three different epithelial cell types were used in this study.
No ethics approval was needed because primary cells were
collected from organs of bovine carcasses at the slaughterhouse
in accordance with the Swiss Federal Animal Protection Law,
RS455. The Madin-Darby Bovine Kidney (MDBK) epithelial
cell line was derived from the kidney of an adult steer in
1957 (Madin and Darby, 1958). PECT cells were prepared
from bovine fetuses from a local abattoir (Schweizer and
Peterhans, 1999; Bürki et al., 2015b). Primary cultures of bovine
mammary gland epithelial cells (bMec) were prepared from
mammary gland tissues of cows directly after slaughter (Wellnitz
and Kerr, 2004; Zbinden et al., 2015). MDBK and PECT
cells were grown in minimal essential medium (MEM)-Earle
medium supplemented with 2.2 g/L NaHCO3 (Biochrom, Berlin,
Germany) and 7% fetal bovine serum (Thermo Fisher Scientific,
Reinach, Switzerland), 1X penicillin-streptomycin (Thermo
Fisher Scientific) and 1% L-glutamine (Biochrom). bMec cells
were grown in Dulbecco’s Modified Eagle’s Medium/Nutrient
Mixture F-12 Ham (DMEM/F-12) containing L-glutamine,
HEPES and sodium bicarbonate (Sigma-Aldrich). DMEM/F-12
was supplemented with 10% fetal bovine serum, 1X penicillin-
streptomycin and 1X insulin-transferrin-selenium (Thermo
Fisher Scientific). All cells were maintained at 37◦C in a
humidified 5% CO2 atmosphere. Cells were routinely screened
by PCR to ensure absence of mycoplasma contamination with the
Venor R©GeM kit (Minerva Biolabs, Berlin, Germany). All bovine
cells used in this study were negative for Mycoplasma sp. The
presence of bovine viral diarrhea virus (BVDV) in cell cultures
was assessed using immunostaining with an in-house swine
anti-BVDV hyperimmune serum (National Reference Center for
BVDV, Institute of Virology and Immunology) as previously
described (Bürki et al., 2015b; Bürgi et al., 2018). bMec cells
were contaminated with BVDV but not PECT and MDBK cells.
Cell passages 5–8 (PECT), 3–5 (bMec), and 117–127 (MDBK)
were used for cell infections. Bovine cells were routinely seeded
24 h before the experiments (Supplementary Table 1). Before
infection withM. bovis, the medium was changed to MEM-Earle
supplemented with 7% fetal bovine serum and 1% L-glutamine
without antibiotics, unless otherwise described. Cells from one
well were counted before infection. 1.5mL of M. bovis pre-
cultures were centrifuged for 15min at 5,900 × g and washed
once in PBS (Thermo Fisher Scientific) at pH 7.5 unless otherwise
described. Mycoplasmas were further suspended and diluted in
MEM-Earle medium to infect cells at a multiplicity of infection
(MOI) ranging between 1.3 and 9 (Supplementary Table 1). The
MOI is defined as the number of added bacteria per individual
host cell. The MOI was confirmed after growth on agar plates.
Adhesion Assays
Adhesion assays were adapted from a previous protocol (Sachse
et al., 1996; Sachse, 1998). The quantification of adherent
M. boviswas carried out using real-time qPCR. Briefly, eukaryotic
cells were seeded as described above to reach high cell
confluency (Supplementary Table 1). Mycoplasma pre-cultures
were washed once and diluted in buffer A (0.05M Tris-HCl,
pH 7.2, 0.1M NaCl, and 1mM CaCl2). Before infection, cells
were washed once with buffer A and blocked for 15min with
buffer A containing 0.1% bovine serum albumin (Sigma Aldrich).
After an additional wash with buffer A, approximately 4 × 105
mycoplasmas were added to the cells. M. bovis was allowed to
adhere to bovine cells for either 30min or 2 h on a rocker with
22 strokes/minute and an amplitude of 3.5 cm at 37◦C. Cells
were washed three times with buffer A to remove unattached
mycoplasmas. Two hundred and fifty microliters of lysis solution
[buffer A with 1% Tween R© 20 (Sigma Aldrich) and 0.24 mg/mL
Proteinase K (Roche Diagnostics, Rotkreuz, Switzerland)] were
added. Plates were covered with a plastic seal and incubated for
80min at 65◦C with horizontal shaking at 500 rpm, followed
by 15min heat-inactivation at 96◦C. These output samples were
collected to quantify the amount of adherent mycoplasmas.
The same amount of bacteria used for infection was directly
lysed in a volume of 250 µL lysis solution (input samples).
To quantify input and output samples, real-time qPCR was
performed on a 7500 real-time PCR system (Thermo Fisher
Scientific) as previously described (Rossetti et al., 2010). The data
were analyzed with the 7500 System Software version v2.0.6 using
auto settings for baseline values and the value of cycle threshold
set at 0.157. Additionally, the specificity of the M. bovis qPCR
was tested with uninfected cells (Supplementary Table 2). The
percentage of adherent M. bovis relative to the input amount of
M. boviswas calculated as follows (adapted fromNicholson et al.,
2012):
% of adherent M. bovis = 2(a−b)∗100 (1)
where, a = Ct of input samples; and b = Ct of output samples.
The assays were performed in triplicates in three independent
experiments.
Cell Infection and Gentamicin Protection
Assay
Cell infections and gentamicin protection assays were adapted
from previous studies using PECT and Bomac cells (Bürki et al.,
2015b; Bürgi et al., 2018). The minimal inhibitory concentration
(MIC) of gentamicin sulfate (TOKU-E Company, Bellington,
USA) in SP4 was assessed by broth microdilution assay according
to the Clinical and Laboratory Standards Institute (CLSI)
guidelines (CLSI, 2011). After 48 h of incubation, the MIC
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for gentamicin was 8 and 4µg/mL for strains JF4278 and
L22/93, respectively. On the other hand, different concentrations
of gentamicin sulfate were tested for efficient killing of the
two strains within 3 h (Supplementary Figure 4). In line with
the previous studies, 400µg/mL gentamicin was required to
efficiently kill the inoculum of M. bovis used for experiments
within 3 h (van der Merwe et al., 2010; Bürki et al., 2015b).
Mycoplasma pre-cultures and eukaryotic cells were prepared
as described above, and the infection details are described
in Supplementary Table 1. After infection, 24-well plates were
centrifuged for 5min at 600 × g to synchronize infection.
Three hours post-infection, cells were washed twice with
PBS. For cell infection assays, fresh MEM-Earle medium was
added. For gentamicin protection assays, MEM-Earle medium
supplemented with 400µg/mL gentamicin sulfate was used to
kill extracellular bacteria. In both assays, cells were incubated
for 3 h (total 6 h post-infection). Subsequently, all samples were
washed three times with PBS and fresh MEM-Earle medium
was added to each well. Sampling was performed at time points
0, 6, and 54 h post-infection. Before sampling, wells were washed
once with PBS at time points 0 and 54 h and three times for
time point 6 h. Bovine cells were scraped and lysed mechanically
using a 23-gauge needle and a syringe. Colony forming units
(CFUs) per well were determined by performing 10-fold serial
dilutions in PBS and subsequent plating on SP4 agar plates. As
controls, assays were performed with M. bovis strains without
bovine cells. These controls were used to check survival of the two
strains in MEM-Earle medium and to validate the efficient killing
of extracellular M. bovis by gentamicin. For this reason, the
controls were performed for each experiment and each cell type.
Since the controls were done in Eppendorf tubes, bacteria were
centrifuged for 15min at 5,900 × g before washing. The assays
were performed in triplicates in three independent experiments.
Confocal Microscopy
To determine the localization of M. bovis after cell infection,
an immunofluorescence staining protocol was established.
Before seeding bovine cells, round glass slides of 12mm
diameter and #1.5 thickness (Neuvitro, Vancouver, USA)
were placed into wells of 24-well plates. Seeding of cells
was adjusted (Supplementary Table 1) to have isolated cells
54 h post-infection. As bMec cells showed reduced adherence
to glass slides, more cells were seeded compared to other
epithelial cells (Supplementary Table 1). Cell infection and
gentamicin protection assays were performed as described
above. At time point 54 h, infected cells were washed twice
with PBS supplemented with 1mM CaCl2 and 1mM MgCl2.
Cells were fixed for 10min at room temperature using a
4% formaldehyde solution (Merck, Schaffhausen, Switzerland)
and subsequently washed four times with PBS. Half of the
samples were permeabilized, to allow intracellular staining.
For permeabilization, 0.2% Triton R© X-100 (Serva, Heidelberg,
Germany) was added to the blocking buffer [5% inactivated horse
serum (Thermo Fisher Scientific) in PBS]. Cells were incubated
for 20min at room temperature (Bürki et al., 2015b) and then
washed four times with PBS. Glass slides were taken out of the
wells and moved to a humidified plastic box for staining. First,
all slides were blocked for 15min using the blocking solution.
Slides were incubated with a stock of in-house rabbit antiserum
directed against PG45T produced in 1975 (1:1,000 in blocking
buffer) for 1 h. After each staining step, slides were washed four
times with PBS. Then Alexa Fluor R© 488-conjugated AffiniPure
Goat anti-rabbit IgGs (H+L) (Jackson ImmunoResearch, Suffolk,
UK) were added as secondary antibodies for 30min (1:400
in blocking buffer). Cells were incubated with 1 mg/ml DAPI
solution (Sigma-Aldrich) (1:1,000 in blocking buffer) for 15min
and with rhodamine phalloidin (PHDR1) (LuBio Science,
Zürich, Switzerland) (100 nM in blocking buffer) for 30min, to
stain cell nuclei and F-actin, respectively. Finally, round glass
slides were mounted on micro slides (Karl Hecht “Assistant”
GmbH, Altnau, Switzerland) using Glycergel mounting medium
(Agilent Technologies AG, Basel, Switzerland). Mounted slides
were examined using an Olympus FV 1000 confocal laser
scanningmicroscope (Olympus, Hamburg, Germany) with a 60X
PlanAPO N objective with oil immersion using the 405, 488,
and 555 nm laser channels. The softwares Fluoview-ASW 3.1 and
ImageJ v1.51n were used to acquire and merge the fluorescence
images.
ApoTox-GloTM Triplex Assay
The ApoTox-GloTM Triplex Assay (Promega,Madison, USA) was
used to assess viability, cytotoxicity and induction of apoptosis
in bovine cells after infection with M. bovis. Viability and
cytotoxicity were measured by fluorescent signals detectable after
cleavage of protease substrates. To measure cell viability, the cell
permeant substrate, is cleaved by a host protease only active
in intact cells. The substrate used to measure cytotoxicity does
not pass intact membranes and is cleaved when a protease is
released into the medium. Induction of apoptosis is quantified
by a luminescent signal derived from the cleavage of a substrate
of activated caspase-3/7. Bovine cells were seeded 24 h before
the start of the experiment in black 96-well plates with a
clear bottom (Greiner Bio-One, Frickenhausen, Germany) as
described before (Supplementary Table 1). After 24 h the cell
medium was replaced with fresh medium and bovine cells
were infected with M. bovis for an additional 24 h. To induce
apoptosis in selected samples, staurosporine was added to the
cells during the last 6 h of infection. Primary bovine cells (PECT
and bMec) were treated with 10µM staurosporine and MDBK
cells with 2.5µM staurosporine. The ApoTox-GloTM Triplex
assay was performed according to the manufacturer’s protocol.
Fluorescence and luminescence signals were read with a Cytation
5 Cell Imaging Multi-Mode Reader (BioTek Instruments GmbH,
Luzern, Switzerland) with the filter settings suggested in the
ApoTox-GloTM Triplex Assay protocol. All the experiments were
performed three times in duplicates.
Proliferation Assay
The iClickTM EdU Andy FluorTM 647 Imaging Kit
(GeneCopoeiaTM, Rockville, USA) was used to determine
the effect of M. bovis on proliferation of bovine epithelial cells.
EdU is an analog of thymidine that is incorporated into DNA
during active DNA synthesis. Due to a copper-catalyzed click
reaction, the Andy Fluor 647 dye can be covalently linked to
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FIGURE 1 | Adhesion assay. M. bovis adhesion to bovine epithelial cells after 30min (A) and 2 h (B). Gray columns correspond to strain JF4278, while spotted
columns correspond to strain L22/93. The x-axis indicates the different bovine cell types used. The y-axis represents the percentage of adherent M. bovis relative to
the added M. bovis. The data shown are the mean values of triplicates from three independent experiments. Standard deviations of measurements are indicated as
vertical bars. *P < 0.05, **P < 0.01.
FIGURE 2 | Infection model of M. bovis with bovine epithelial cell types. Survival of M. bovis in MEM-Earle medium without cells (A). Survival and growth of M. bovis in
co-culture with cells (B). Gray columns correspond to strain JF4278, while spotted columns correspond to strain L22/93. The x-axis indicates the different bovine cell
types and time points. The y-axis represents the log10 CFU/well of M. bovis. The data shown are the mean values of triplicates from three independent experiments.
Standard deviations of measurements are indicated as vertical bars. Statistical analysis within the individual time points are shown. Bacterial concentrations of the two
strains within each cell type were analyzed. Bacterial concentrations of the same strain between different cell types were analyzed. *P < 0.05, **P < 0.01.
the incorporated EdU. Thus, proliferating cells are stained
with Andy Fluor 647. Bovine cells were seeded 24 h before
the start of the experiment in black 96-well plates with a clear
bottom (Supplementary Table 1). After 24 h, the cell medium
was replaced with MEM-Earle without fetal bovine serum and
incubated for 30min. Before infection, the cell medium was
replaced with MEM-Earle containing 2% fetal bovine serum,
instead of 7% as used in other assays. Compared to the other
assays, the MOI was reduced to ensure lower bacterial load per
cell for subsequent image acquisition (Supplementary Table 1).
Ten µM EdU were added to the cells during the last 4 h of
infection. After a total of 24 h of infection, cells were washed
once with buffer A (as used in adhesion assays). Cells were
then fixed with 3.7% formaldehyde solution for 15min and
permeabilized with ice-cold 100% methanol for 10min at
−20◦C. Before staining, cells were washed twice with buffer
A containing 3% bovine serum albumin. Subsequently, the
copper-catalyzed click reaction with the Andy Fluor 647 dye
was performed according to the manufacturer’s protocol in a
total volume of 50 µL/well. Finally, staining of M. bovis and
eukaryotic nuclei was performed as described above. However,
dilutions of antibodies and dyes and washings between staining
steps were done with buffer A containing 3% bovine serum
albumin.
Cells were visualized using the INCell Analyzer 2000 system
(General Electric Healthcare, Glattbrugg, Switzerland). Images
were obtained using a wide field epifluorescence microscope
with a Nikon objective lens (20X/NA 0.45), at a working
distance of 7.5mm. The following filter sets were used: FITC
(490_20× & 525_36m) for the visualization of Alexa Fluor R©
488 stained M. bovis, Cy5 (645_30× & 705_72m) for Andy
Fluor 647 stained DNA and DAPI (350_50× & 455_60m) for
Hoechst stained nuclei. Bright-field images were acquired to
visualize the morphology of cells. Images were analyzed using
the INCell Investigator 1.6.2 software (GE Healthcare). An
example for image analysis is shown in Supplementary Figure 1.
After image segmentation of the DAPI signal, a pseudo-cell
was defined around the nuclei by expanding the nuclear mask
by 44.4µm in diameter. To ensure that adjacent cells were
separated, a clump-breaking algorithm was applied. Within the
area of each of the defined pseudo-cells, the intensity of the
Cy5 and FITC signal was measured. In an additional step, Cy5
positive cells were checked for overlappingDAPI andCy5 signals.
The data of each cell was exported to a MS Excel file. Cells
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were grouped in Cy5 positive (proliferating) and negative (non-
proliferating) cells. Additionally, the intensity of fluorescent
signal for M. bovis within these cells was estimated. Thus, the
amount of bacteria associated with each cell was measured.
Finally, cells were grouped in quartiles according to theirM. bovis
association. All the experiments were performed three times in
duplicates.
Statistical Analysis
For all assays, absolute or relative values are shown as means
± standard deviations of mean values from three independent
experiments. The significance of differences between uninfected
and infected cells with either strain was calculated with the
Welch’s t-test. Where indicated, the significance of differences
between different cell types infected with the same strain or
treated with the same compound was calculated with the Welch’s
t-test. Statistical analysis was performed using the software
GraphPad InstatTM V2.05 (GraphPad Software Inc., La Jolla, CA,
USA).
RESULTS
Adhesion Capacity of M. bovis Is
Dependent on Time and Bovine Cell Type
Adhesion of M. bovis strains JF4278 and L22/93 to bovine
epithelial cell types was evaluated. As shown in Figure 1,
adherence of M. bovis was expressed as the percentage of the
initial inoculate of M. bovis. After 30min, between 4.3% (strain
L22/93 with bMec cells) and 9.3% (strain JF4278 with MDBK
cells) of M. bovis adhered to bovine epithelial cells (Figure 1A).
Adhesion capacity of M. bovis strain JF4278 to bMec cells
was found to be significantly lower compared to the other cell
types (Figure 1A). L22/93 showed a significantly lower adhesion
capacity to bMec cells in comparison to PECT cells (Figure 1A).
After 2 h of incubation, adhesion of M. bovis increased with
percentages ranging between 13.1% (strain L22/93 with bMec
cells) and 26.3% (strain JF4278 with MDBK cells) (Figure 1B). A
higher adhesion capacity ofM. bovis, especially for strain JF4278,
to the bovine cell line compared to primary cells was observed
(Figure 1B). Generally, adhesion of JF4278 was slightly higher
than strain L22/93 (Figures 1A,B). However, this difference
was shown to be significant only for MDBK cells after 2 h of
incubation (Figure 1B).
M. bovis Is Able to Invade and Grow in
Co-culture With Different Bovine Epithelial
Cell Types
M. bovis invasion and growth in co-culture were assessed.
For each individual cell infection experiment and gentamicin
protection assay, controls with M. bovis in cell culture medium
without cells and with and without gentamicin were included
(Figure 2A and Figure 3A). Since these controls were performed
for each individual cell infection experiment, cell types are
indicated in the graph although no eukaryotic cells were present.
M. bovis did not grow in cell culture medium, since bacterial
concentrations decreased after 6 h incubation in MEM-Earle
medium (Figure 2A). L22/93 died after 54 h incubation in all
experiments, while in the case of JF4278, a small quantity of
bacteria could be detected in one case at 54 h (Figure 2A). Loss of
M. bovis cells occurs during washing steps, therefore the inability
of both strains to grow in MEM-Earle medium without washing
steps was confirmed in a previous study (Bürgi et al., 2018).
However, growth in spent MEM-Earle medium, i.e., medium
pre-incubated with eukaryotic cells, cannot be ruled out as is
seen for Bomac cells (Bürgi et al., 2018). Since M. bovis could
only require the presence of eukaryotic metabolites to grow
in MEM-Earle medium (Bürgi et al., 2018), “growth in co-
culture” rather than “cell-associated growth” best describes the
observed growth. When no gentamicin is added, both M. bovis
strains survived in co-culture with bovine epithelial cell types,
and a slight increase of mycoplasmal concentration was seen
after 54 h of incubation compared to 0 and 6 h post-infection
(Figure 2B). A significant difference in bacterial counts between
JF4278 and L22/93 was detected with MDBK cells 6 h post-
infection. Furthermore, 54 h post-infection, a significantly higher
concentration of JF4278 compared to L22/93 was observed with
MDBK and PECT cells. Additionally, higher concentrations of
JF4278 were reached with MDBK cells compared to primary
cells, while higher concentrations were observed in co-culture
with bMec cells than with PECT cells (Figure 2B). The efficient
killing of mycoplasmas with 3 h gentamicin treatment is shown
in Figure 3A. After the gentamicin treatment, no viable bacteria
could be recovered without co-cultivation with eukaryotic cells
(Figure 3A). The gentamicin protection assay is shown in
Figure 3B. When epithelial cells were present, a small amount of
viableM. bovis was detected 6 h post-infection. Since gentamicin
was shown to efficiently kill all “unprotected” mycoplasmas, the
recovered bacteria 6 h post-infection correspond to the number
of M. bovis that invaded bovine epithelial cells. No significant
difference in the number of recovered bacteria was observed
among the different cell types or M. bovis strains at this time
point (Figure 3B). Regarding the invasion rates of the two M.
bovis strains, they were comparable in all three epithelial cell
types.
Growth of M. bovis Strain L22/93 Is
Strongly Reduced in Co-culture With
Bovine Mammary Gland Epithelial Cells
Compared to Other Epithelial Cell Types
Growth of M. bovis in co-culture with bovine epithelial cells
during the gentamicin protection assay was assessed 54 h post-
infection. A significantly higher concentration of JF4278 was
observed in co-culture with MDBK cells compared to PECT cells
(Figure 3B). Additionally, significantly higher concentrations of
JF4278 compared to L22/93 were measured in co-culture with all
epithelial cell types (Figure 3B). This observation was even more
pronounced with bMec cells (Figure 3B). Fifty-four hours post-
infection, co-culture of L22/93 with bMec cells reached 300X and
60X lower titers in MDBK and PECT, respectively. On the other
hand, differences in titers of JF4278 54 h post-infection were not
>10-fold among epithelial cells.
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FIGURE 3 | Gentamicin protection assay. Survival of M. bovis in MEM-Earle medium with gentamicin treatment without cells (A) and gentamicin protection assay (B).
Gray columns correspond to strain JF4278, while spotted columns correspond to strain L22/93. The x-axis indicates the different bovine cell types used and time
points. The y-axis represents the log10 CFU/well of M. bovis. The data shown are the mean values of triplicates from three independent experiments. Standard
deviations of measurements are indicated as vertical bars. Statistical analysis within the individual time points are shown. Bacterial concentrations of the two strains
within each cell type were analyzed. Bacterial concentrations of the same strain between different cell types were analyzed. *P < 0.05, **P < 0.01.
Confocal Fluorescence Microscopy
Reveals Intra- and Extracellular
Localization of M. bovis
Confocal fluorescence microscopy was used to confirm extra-
and intracellular localization of M. bovis after cell infection and
gentamicin protection assays. Fifty-four hours post-infection,
cells were either fixed or fixed and then permeabilized. Pictures
from uninfected cells were acquired and no unspecific staining
for M. bovis was observed (Supplementary Figure 2). Without
gentamicin treatment, extracellular and cell-associated as well as
intracellular bacteria were observed in all cell types (Figure 4).
No obvious difference in the localization of bacteria between the
two M. bovis strains was detected. In the gentamicin protection
assays, extracellular and intracellular bacteria were visualized at
54 h post-infection (Figure 4). Moreover, in gentamicin-treated
and unpermeabilized cells,M. bovis was observed outside of cells
(Figure 5). Furthermore, some intracellularly localized bacteria
could be detected in fixed cells, indicating some permeabilization
of cells during the fixation step (Figure 5). The formaldehyde
solution used in the fixation step contains 0.4% methanol as a
stabilizer, hence a weak permeabilization of the cell membrane
occurring during fixation cannot be ruled out. In general, more
bacteria were detected when infection was performed with
JF4278 than with L22/93 (Figures 4, 5). Additionally, more
mycoplasmas were found to be present in samples initially
not treated with gentamicin compared to samples from the
gentamicin protection assay (Figures 4, 5). These differences
between the two strains and treatments are in line with the
CFUs/well values counted during cell infections (Figure 2B) and
gentamicin protection assays (Figure 3B).
M. bovis strain L22/93 Has Minor Effects
on bMec Cells, but Induces Apoptosis or
Cytotoxic Effects in Other Bovine Epithelial
Cells
Viability, cytotoxicity, and induction of apoptosis in bovine
epithelial cells after infection with M. bovis were assessed using
the ApoTox-GloTM Triplex assay. Fluorescence and luminescence
intensity values were expressed relative to the corresponding
uninfected cells (Figure 6). Cell viability after infection with
strain JF4278 did not drastically change in the tested cell
types compared to uninfected cells (Figure 6A). However,
viability of MDBK and PECT cells decreased after infection
with strain L22/93 to 74 and 60% relative to uninfected
cells (Figure 6A). As strain L22/93 did not reduce viability
of bMec cells, a significant difference to the relative values
for MDBK and PECT cells infected with L22/93 was detected
(Figure 6A). Cytotoxicity was significantly increased after M.
bovis infection in MDBK cells infected with both strains
and in PECT cells with strain L22/93 (Figure 6B). L22/93
showed a higher cytotoxic effect in PECT cells compared with
MDBK and bMec cells (Figure 6B). Efficiency of caspase-3/7
activation was assessed with staurosporine treatment of epithelial
cells (Supplementary Figure 3). Apoptosis was significantly
induced only in MDBK cells after infection with strain L22/93
(Figure 6C). Strain L22/93 strongly induced cytotoxicity in PECT
cells and apoptosis in MDBK cells but not with bMec cells. This
is in line with the reduced viability values in MDBK and PECT
cells compared to the bMec cells after infection with L22/93.
M. bovis Infection Has Variable,
Dose-Dependent Effects on Proliferation of
Primary Epithelial Cells
Proliferation of bovine cells after infection with M. bovis was
measured using a high-throughput image analysis approach.
For uninfected and infected cells, a total of minimum 25,818
(PECT cells infected with JF4278) and maximum 42,351 (bMec
cells infected with L22/93) individual cells were analyzed. The
percentage of proliferating cells was calculated and expressed
relative to uninfected cells. To measure the amount of bacteria
associated with each cell, a pseudo-cell was defined around each
nucleus (example for MDBK cells in Supplementary Figure 1).
Afterwards, the intensity of the fluorescent signal for M.
bovis within this cell was quantified and cells were grouped
in quartiles accordingly. In PECT cells, proliferation was
increased after infection with strain JF4278 when compared
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 September 2018 | Volume 8 | Article 329
Josi et al. Mycoplasma bovis Cell Infection Models
FIGURE 4 | Confocal fluorescence microscopy of cell infections and gentamicin protection assays with fixed and permeabilized cells. Time point 54 h post-infection.
MDBK cells (A), PECT cells (B), and bMec cells (C). Stained nuclei are in blue, F-actin is in red, and mycoplasmas are in green. Images were merged and the
magnification was 600X. The two upper images of each figure represent infected cells without gentamicin treatment. The two lower images represent infected cells
with gentamicin treatment. The inset represents an area of interest and is shown in two-fold magnification in each image. Orange arrows indicate extracellular and
cell-associated M. bovis. White arrows indicate intracellular M. bovis.
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FIGURE 5 | Confocal fluorescence microscopy of cell infections and gentamicin protection assays with fixed cells. Time point 54 h post-infection. MDBK cells (A),
PECT cells (B), and bMec cells (C). Stained nuclei are in blue, F-actin is in red, and mycoplasmas are in green. Images were merged and the magnification was 600X.
The two upper images of each figure represent infected cells without gentamicin treatment. The two lower images represent infected cells with gentamicin treatment.
The inset represents an area of interest and is shown in two-fold magnification in each image. Orange arrows indicate extracellular and cell-associated M. bovis. White
arrows indicate intracellular M. bovis.
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to strain L22/93 (Figure 7A). Moreover, JF4278 induced more
cell proliferation in PECT cells than in MDBK and bMec cells
(Figure 7A). The results were then analyzed taking into account
the amount of bacteria associated with each cell. While for
primary cells dose dependent effects were observed, differences
in MDBK cells were marginal (Figures 7B-D). JF4278 induced
proliferation in primary cells compared to uninfected cells
when small quantities of bacteria were associated with each cell
(Figures 7C,D). This observation was not statistically significant
for L22/93 (Figures 7C,D). For both M. bovis strains, a step-
wise reduction in proliferating eukaryotic cells was observed in
PECT and bMec cells associated with an increased amount of
M. bovis (Figures 7C,D). Moreover, a significant reduction of
proliferation was observed for primary cells with the highest
L22/93 association compared to uninfected cells (Figures 7C,D).
DISCUSSION
Tissue predilection and cell permissivity of specific M. bovis
strains are not known, and the cause for the increased severity
of mastitis cases observed in Switzerland remains elusive (Bürki
et al., 2016). Recently, the genetic characterization of M.
bovis isolates from cattle and bison suggested host-specific
genotypes (Register et al., 2015). It was later shown that M.
bovis isolates from bison and cattle display differential effects
on inhibition of cell proliferation and delay of apoptosis in
bovine and bison blood cells (Suleman et al., 2016). Invasiveness
of M. bovis isolates from bison was shown to be reduced
compared to an isolate from a calf in the EBL cell line
but not in the EBTr cell line (Suleman et al., 2016). This
observation has not been explained and should be addressed by
additional experiments. In this study, we investigated adhesion,
cell invasion, cytotoxicity, induction of apoptosis, and cell
proliferation in bovine epithelial cells using two M. bovis
strains.
Both strains of M. bovis were able to adhere to all bovine
epithelial cells. The adherence rate was in the range of previous
studies (Sachse et al., 1996; Thomas et al., 2003a,b). However,
our quantitation protocol has the advantage of not requiring
specialized training or waste management as is necessary when
experiments involve radioactive metabolic labeling. Both strains
showed higher adherence to the cell line compared to primary
cells (Figure 1) but JF4278 displayed higher adhesion rates than
L22/93 to all three epithelial cells. These experiments did not
reveal adhesion predilection of one strain to a specific cell
type. A previous study was also unable to associate adherence
FIGURE 6 | ApoTox-GloTM Triplex assay. Viability (A), cytotoxicity (B), and apoptosis induction in eukaryotic cells (C). Time point 24 h post-infection. Black columns
correspond to uninfected cells, gray columns correspond to strain JF4278, while spotted columns correspond to strain L22/93. The x-axis indicates the different
bovine epithelial cell types used. The y-axis represents the values for the respective test relative to uninfected cells. The values obtained for each cell type infected with
M. bovis were normalized to values of the corresponding uninfected cells of each cell type. The data shown are the mean values of duplicates from three independent
experiments. Standard deviations of measurements are indicated as vertical bars. Statistical analysis of the two strains within each cell type and the same strain
between different cell types are shown. *P < 0.05, **P < 0.01.
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FIGURE 7 | Proliferation assay. Total cell proliferation due to M. bovis (A). Cell proliferation dependent on the amount of bacteria associated with each cell (MDBK: B,
PECT: C, and bMec: D). Black columns correspond to uninfected cells, gray columns correspond to strain JF4278, while spotted columns correspond to strain
L22/93 (A). In panels (B–D), gray columns correspond to M. bovis infection. Additionally, gray columns with horizontal or vertical lines and white columns with
horizontally or vertically dashed lines correspond to low, medium-low, medium-high, and high M. bovis association, respectively. The x-axis indicates the different
bovine epithelial cell types and the M. bovis strain. The y-axis represents the values for proliferation relative to uninfected cells. The data shown are the mean values of
duplicates from three independent experiments. Standard deviations of measurements are indicated as vertical bars. In panel (A), statistical analysis of the two strains
within each cell type and the same strain between different cell types are shown. In Figures (B–D), statistical analysis of proliferation values for individual cell types
dependent on M. bovis association for the same strain are shown.*P < 0.05, **P < 0.01.
tropism of certain cells types to M. bovis isolates from different
organs.
Invasion of epithelial cells by M. bovis was assessed by
two complementary methods, gentamicin protection assays
and confocal fluorescence microscopy. Both assays led to the
identification of intracellular bacteria (Figures 3B, 4). These
findings support previous in vitro and in vivo observations with
epithelial cells from the respiratory tract (Rodríguez et al., 1996;
Maeda et al., 2003; Bürki et al., 2015b; Suleman et al., 2016).
However, M. bovis was not detected in the cytosol of epithelial
cells of the udder collected from pathological material (Stanarius
et al., 1981; Radaelli et al., 2011), while invasion of bMec cells
was observed (Figures 3B, 4C). The in vivo relevance of invasion
of epithelial mammary gland cells has not yet been defined.
These results suggest that the “severe mastitis phenotype” is not
associated with differential invasiveness of the two testedM. bovis
strains. However, after 54 h of co-infection with bMec cells in the
gentamicin protection assay, the L22/93 strain has a significant
lower titer compared to JF4278 (Figure 3B). This significant
difference in titers between the two strains was found to be more
prominent in co-culture with bMec cells compared to the other
cell types. This cannot be explained by the reaching of a growth
plateau. Indeed, at the same time point without supplementation
of gentamicin, approximately 105 L22/93 were recovered
(Figure 2B). Moreover, no statistically relevant differences were
observed in the cytotoxic effect of both strains toward bMec cells.
Further studies will be necessary to assess if this discrepancy
is a true variation in generation time between the two strains
in co-culture with bMec cells. Confocal fluorescent microscopy
showed M. bovis inside and outside bovine cells (Figure 4).
In a previous study using a similar protocol, no extracellular
mycoplasmas were detected after the initial treatment of cells
with gentamicin (Bürki et al., 2015b). The discrepancy observed
between the two studies might be explained by technical reasons.
In the present study a rabbit polyclonal antiserum directed
against PG45T was used as primary antibody, while in the
previous study a mouse monoclonal IgG1 primary antibody
was used (Bürki et al., 2015b). The polyclonal serum might
be more sensitive than monoclonal antibodies since it targets
more epitopes. Additionally, the previous experiments were
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performed using epifluorescence and not confocal microscopy.
It is not clear whether the mycoplasmas detected outside cells
after the gentamicin treatment evaded cells and reattached, as
suggested with the closely related M. agalactiae, or if they derive
from lysed eukaryotic cells (Hegde et al., 2014). After 24 h
of infection with M. bovis, cytotoxicity was slightly increased
in all the cell types (Figure 6B). Therefore, cell disruption
cannot be ruled out as a source of extracellular mycoplasmas
after 54 h of infection. Collectively, the confocal fluorescence
microscopy shows occasional intracellular localization of M.
bovis in epithelial cell types and confirms the results from the
gentamicin protection assay.
Strain L22/93 showed a higher cytotoxic effect toward PECT
cells and induced more apoptosis in MDBK cells compared to
bMec cells (Figure 6). Although this is not definitive evidence, it
might be linked to the reduced growth of L22/93 in co-culture
with bMec cells (Figure 3B). Indeed, lower mycoplasma counts
during infection could lead to decreased severity of the disease
(Nilsson et al., 2010). In in vivo experiments, low infectious
doses of M. bovis produced significantly fewer lung lesions and
cytopathic effects compared to high infectious doses (Prysliak
et al., 2011). Similarly, another in vitro study showed that high
M. bovis counts reduced viability and increased expression of
pro-inflammatory cytokines in PBMCs (Gondaira et al., 2015).
Additionally, anM. bovis encoded secretory nuclease was shown
to induce cytotoxicity and apoptosis in a dose dependent manner
in Bomac cells (Zhang et al., 2016). The growth rate of specific
strains of M. bovis in organs or cells might be a relevant
parameter in the development of lesions. However, JF4278 did
not significantly alter viability of infected cells (Figure 6A). Since
JF4278 generally reaches higher titers than strain L22/93 in co-
culture with epithelial cells (Figure 3B), a sole dependency on
the amount of mycoplasmas on the reduction of cell viability
is questionable. Additionally, bMec cells were found to be
contaminated with BVDV. Although interactions with BVDV
cannot be totally excluded, a previous study showed that co-
infection with BVDV in Bomac cells did not substantially
change cell invasion, mycoplasmal growth or cytotoxicity after
infection with M. bovis (Bürgi et al., 2018). Furthermore,
cytotoxicity was slightly but often not significantly increased
after infection with M. bovis in all cell types (Figure 6B). As
mentioned above, apoptosis was induced in MDBK cells infected
with L22/93. However, induction of apoptosis was found to
be unchanged in primary epithelial cells infected with either
strain ofM. bovis (Figure 6C). Therefore, other cell death routes
might be of importance for M. bovis infected epithelial cells.
Bacterial infections were shown to trigger caspase-1 associated
pyroptosis and TNF-induced necrosis (Blériot and Lecuit, 2016).
Additionally, activated caspase-1 is involved in the cleavage
and activation of pro-IL1-β and pro-IL-18 (Blériot and Lecuit,
2016). Since, epithelial cells were shown to be the source of pro-
inflammatory cytokines like TNF-α and IL1-β after infection with
M. bovis (Zbinden et al., 2015; Wang et al., 2016; Gondaira et al.,
2018), these cell death routes could be of importance for infected
epithelial cells.
Cytotoxicity due to M. bovis was not as evident as with M.
mycoides mycoides (Pilo et al., 2005). Cell proliferation was
tested to assess if cell death might be concealed/obscured by
increased cell division. Cell proliferation was not increased
by M. bovis compared to uninfected cells. Therefore,
the cytotoxicity measured was not associated with cell
proliferation. However, low concentrations of JF4278
increased proliferation of primary epithelial cells significantly
compared to uninfected cells (Figures 7C,D), but when
cells are associated with large amounts of mycoplasmas the
proliferative effect is lost. High amounts of strain L22/93
associated with cells even led to an anti-proliferative
response of primary epithelial cells. The same observation
was also previously made with PBMCs (Suleman et al.,
2018). However, the in vivo relevance of this finding is not
clear.
In summary, this study showed no adherence predilection
to specific epithelial cells associated with strains JF4278 and
L22/93. M. bovis is able to invade different epithelial cells
in vitro, including epithelial mammary gland cells. However,
no differences in invasion rates were observed between
the two strains. Furthermore, a dose dependent effect of
M. bovis on proliferation of primary epithelial cells was
observed. Strain L22/93 showed less severe cytopathic effects
on bMec cells compared to MDBK and PECT cells and
this could be linked to the bacterial titers measured in
co-culture with the respective epithelial cells. However, a
direct link between bacterial titers reached during gentamicin
protection assays and the reduced viability of PECT and
MDBK cells would require further proof. Future studies
should focus on the induction of cell death pathways in
different infected cell types. Moreover, two recently published
genomics studies characterized several factors potentially related
to M. bovis virulence (Parker et al., 2016; Rasheed et al.,
2017). Functional genomic studies will be required in the
future.
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Supplementary Figure 1 | Example of image segmentation for the proliferation
assay. Images of uninfected and M. bovis infected MDBK cells. Time point 24 h
post-infection. DAPI (Hoechst stained nuclei), FITC (Alexa Fluor® 488 stained M.
bovis), Cy5 (Andy Fluor 647 stained DNA with EdU), and bright-field images
(morphology of cells) are shown. The magnification was 200X. Images were
analyzed using the INCell Investigator 1.6.2 software (GE Healthcare). After image
segmentation on the DAPI signal (blue circle around the nuclei), a pseudo-cell was
defined around the nucleus by expanding the nuclear mask by 44.4µm in
diameter (yellow pseudo-cell circle for each nucleus). To ensure that adjacent cells
were separated, a clump-breaking algorithm was applied (no overlapping
pseudo-cells). Within the area of each of the defined pseudo-cells the intensity of
the Cy5 and FITC signal was measured (not shown in this picture; values were
exported to a MS Excel file). In an additional step, Cy5 positive cells were checked
for overlapping DAPI and Cy5 signals (red circle around Cy5 positive nuclei). All
experiments were performed three times in duplicates. In the case of the
uninfected MDBK cells a total of 29,842 individual cells were analyzed, whereas
for MDBK cells infected with strain JF4278 a total of 30,762 cells were analyzed.
Supplementary Figure 2 | Confocal fluorescence microscopy of cell infections
and gentamicin protection assays with uninfected cells. Time point 54 h
post-infection. MDBK cells (A), PECT cells (B), and bMec cells (C). Stained nuclei
are in blue, F-actin is in red, and mycoplasmas are in green. Images were merged
and the magnification was 600X. The two upper images of each figure represent
uninfected cells without gentamicin treatment. The two lower images of each
figure represent uninfected cells with gentamicin treatment. Fixed cells are shown
in the left images, whereas fixed and permeabilized cells are shown in the images
on the right.
Supplementary Figure 3 | Apoptosis induction with staurosporine. Apoptosis
induction in uninfected cells by staurosporine. Black columns correspond to
uninfected cells, checkered columns correspond to uninfected cells +
staurosporine. The x-axis indicates the different bovine epithelial cell types used.
The y-axis represents the values for the apoptosis induction test relative to
uninfected cells. The values obtained for each cell type treated with staurosporine
were normalized to values of the corresponding untreated cells of each cell type.
The data shown are the mean values of duplicates from three independent
experiments. Standard deviations of measurements are indicated as vertical bars.
Statistical analysis between untreated and staurosporine-treated cells within each
cell type are shown. ∗P < 0.05, ∗∗P < 0.01.
Supplementary Figure 4 | Efficient killing of M. bovis by gentamicin. Survival of
M. bovis in MEM-Earle medium with gentamicin treatment without cells. Gray
columns correspond to strain JF4278, while spotted columns correspond to strain
L22/93. The x-axis indicates the different time points and the gentamicin
concentration used. The y-axis represents the log10 CFU/well of M. bovis. The
data shown are the mean values of duplicates. Standard deviations of
measurements are indicated as vertical bars.
Supplementary Table 1 | Overview of the infection parameters for the different
assays.
Supplementary Table 2 | Real-time qPCR results of uninfected bovine epithelial
cells.
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